JULIO
SANJUAN ARIAS
TITULAR DE UNIVERSIDAD
Eli Lilly and Company
Indianapolis, EE. UU.Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (3)
2022
-
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Nature, Vol. 604, Núm. 7906, pp. 502-508
2014
-
Common variant at 16p11.2 conferring risk of psychosis
Molecular Psychiatry, Vol. 19, Núm. 1, pp. 108-114
2006
-
Quality of life and social functioning in schizophrenic patients treated with olanzapine: 1 Year follow-up naturalistic study
Actas Espanolas de Psiquiatria, Vol. 34, Núm. 1, pp. 7-15